Publications
- Cytochrome b(5) shifts oxidation of the anticancer drug ellipticine by cytochromes P450 1A1 and 1A2 from its detoxication to activation, thereby modulating its pharmacological efficacy2011 | Faculty of Science
- The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism2007 | Faculty of Science
- Kinetics of ellipticine oxidation by cytochromes P450 1A1 and 1A2 reconstituted with NADPH:cytochrome P450 reductase2007 | Faculty of Science
- Role of cytochromes P450 and peroxidases in metabolism of the anticancer drug ellipticine: additional evidence of their contribution to ellipticine activation in rat liver, lung and kidney2010 | Faculty of Science
- Preparation of apo-cytochrome b5 utilizing heme transfer to apo-myoglobin2009 | Faculty of Science, First Faculty of Medicine, Faculty of Mathematics and Physics
- Optimization of preparation of apo-cytochrome b5 utilizing apo-myoglobin2008 | Faculty of Science
- Preparation of apo-cytochrome b5 utilizing apo-myoglobinPublication without faculty affiliation
Loading network view...